- July 21, 2021Source: WTNH News 8
Wednesday’s Warrior: Tom the Pianist Routinely Visits Smilow Cancer Hospital to Perform for Patients
- July 21, 2021
Thoracic Oncology Specialty Team
- July 21, 2021
Ariel Jaffe, MD, joins Liver Cancer Program at Smilow Cancer Hospital
- July 21, 2021
Colorectal Cancer and Women
- July 21, 2021
Smilow Cancer Hospital Care Center at Orange
- July 21, 2021
Meet the Physician: Harriet Kluger, MD
- July 20, 2021
Studying Cancer Patients Who Received COVID-19 Vaccines
- July 20, 2021
Yale Cancer Center and Smilow Cancer Hospital Remind You to Schedule Cancer Screenings
- July 20, 2021
Dr. Cecelia Calhoun joins Yale Hematology and Pediatrics
- July 20, 2021
Renewed Energy in Breast Cancer Care
- July 20, 2021
A Faster, Broader Pipeline for Phase I Clinical Trials
- July 20, 2021
Finding a Sense of Normalcy
- July 19, 2021Source: The Washington Post
Throughout U.S., Workers Had to Choose between Following COVID-19 Guidance and Keeping Their Jobs
- July 15, 2021
Meet Dr. Tara Sanft
- July 15, 2021
Meet Dr. Lynn Tanoue
- July 14, 2021
Joseph W. Kim Receives Prestigious 2021 Cancer Clinical Investigator Team Leadership Award
- July 13, 2021Source: News Wise
Scientists Repurpose Cancer and Seizure Medications to Aid in the Fight against COVID-19
- July 08, 2021Source: Yale Insights
The Fight for Healthcare Equity after COVID-19
- July 07, 2021Source: NBC Connecticut
Smilow Cancer Hospital Coordinator Goes 100 Extra Miles for Patients
- July 07, 2021
Yale Cancer Center Shares Five Things You Need to Know About Sarcoma, a Rare Cancer
Yale Cancer Center News
Centerpoint Magazine - Spring/Summer 2021
Twitter Feed
@YaleCancer Retweeted @SmilowCancer"I study cancer outcomes. My specific focus looks at the burden of breast cancer care on patients' lives."— breast surgeon Dr. Rachel Greenup @GreenupRachel shares how her research impacts her clinical practice @SmilowCancer. @YaleCancer @YaleMed @YNHH @yalesurgery #bcsm https://t.co/nYMMsfWnJfA DAY AGO
@YaleCancer"Oncologists should weigh the risks & benefits of moving forward with an available PD-1 inhibitor in combination with chemotherapy." —@BarbaraBurtness reviewing recent trial data for #headandneckcancer in @practiceupdate. @SmilowCancer @YaleMed @YNHH
https://t.co/rbiH1AIuaS https://t.co/EjqFED0P8p4 DAYS AGO
@YaleCancer“Patients have to make a decision between, ‘do I go and earn a living or do I comply by these guidelines that were set without maybe consideration of all facets of society?’” @cececalhounMD via @washingtonpost @YaleMed @SmilowCancer https://t.co/vzkjK4Zy57 https://t.co/8FxOUDG2AN4 DAYS AGO